Beacon Therapeutics

CEO - David Fellows

Country: UK | Funding: $290.1M (+)

Website: https://www.beacontx.com

Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.

Competitors